104,95 €
104,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
52 °P sammeln
104,95 €
104,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
52 °P sammeln
Als Download kaufen
104,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
52 °P sammeln
Jetzt verschenken
104,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
52 °P sammeln
  • Format: PDF

This title includes a number of Open Access chapters. Nutrition is becoming ever more central to our understanding of metabolic processes. Nutritional biochemistry offers insight into the mechanisms by which diet influences human health and disease. This book focuses on five aspects of this complex field of study: nutritional genomics, clinical nut

Produktbeschreibung
This title includes a number of Open Access chapters. Nutrition is becoming ever more central to our understanding of metabolic processes. Nutritional biochemistry offers insight into the mechanisms by which diet influences human health and disease. This book focuses on five aspects of this complex field of study: nutritional genomics, clinical nut

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Dr. Chad L. Cox is an adjunct professor in the Department of Chemistry and the Department of Family and Consumer Sciences at California State University, Sacramento. He also teaches at Sacramento City College, the University of Phoenix, and the University of California, Davis. He holds a PhD in nutritional biology, a bachelor of science in exercise biology, and a bachelor of science in nutrition science, all from UC Davis. His research interests include the causes of obesity and obesity-related chronic diseases, how exercise training can induce changes in the regulation of gene expression that can lead to improvements in insulin sensitivity and promote energy balance, and the development of pharmacological agents that could help reduce the epidemic of obesity, Type 2 diabetes, and metabolic syndrome.